Publicacions
-
Koncar RF, Dey BR, Stanton AJ, Agrawal N, Wassell ML, McCarl LH, Locke AL, Sanders L, Morozova-Vaske O, Myers MI, Hamilton RL, Carcaboso AM, Kohanbash G, Hu B, Amankulor NM, Felker J, Kambhampati M, Nazarian J, Becher OJ, James CD, Hashizume R, Broniscer A, Pollack IF and Agnihotri S.
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas
CANCER RESEARCH . 79(16): 4026-4041. Nº de cites: 22
-
Aschero MR, Torbidoni A, Sampor C, Laurent V, Zugbi S, Winter U, Lubieniecki F, Alonso D, Schaiquevich P and Chantada G.
Minimally disseminated disease and outcome in overt orbital retinoblastoma
PEDIATRIC BLOOD & CANCER . 66(6): . Nº de cites: 5
-
de Rojas T, Clementel E, Giralt J, Cruz-Martínez O, Boterberg T, Kortmann RD, Gaze MN, Moreno L, Janssens GO and SIOP-Europe QUARTET Project and of the EORTC.
Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.
EUROPEAN JOURNAL OF CANCER . 114: 36-46. Nº de cites: 9
-
Carvalho D, Taylor KR, Gene-Olaciregui N, Molinari V, Clarke M, Mackay A, Ruddle R, Henley A, Valenti M, Hayes A, Brandon AH, Eccles SA, Raynaud F, Boudhar A, Monje M, Popov S, Moore AS, Mora J, Cruz-Martínez O, Vinci M, Brennan PE, Bullock AN, Carcaboso AM and Jones C.
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Communications Biology . 2: 156-156. Nº de cites: 66
-
Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Gene-Olaciregui N, Tabatabai G, Carcaboso AM, Aboagye EO, Suwan K and Hajitou A.
Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma
EMBO Molecular Medicine . 11(4): . Nº de cites: 55
-
Puerto-Camacho P, Amaral AT, Lamhamedi-Cherradi SE, Menegaz BA, Castillo H, Ordóñez JL, Dominguez-Hormaetxe S, Jordan-Perez C, Diaz-Martin J, Romero-Pérez L, Lopez-Alvarez M, Civantos-Jubera G, Robles-Frias MJ, Biscuola M, Ferrer C, Mora J, Cuglievan B, Schadler KL, Seifert O, Kontermann RE, Pfizenmaier K, Simon L, Fabre M, Carcaboso AM, Ludwig JA and de Álava E.
Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma
CLINICAL CANCER RESEARCH . 25(7): 2228-2240. Nº de cites: 30
-
Asnaghi L, White DT, Key N, Choi J, Mahale A, Alkatan H, Edward DP, Elkhamary SM, Al-Mesfer S, Maktabi A, Hurtado CG, Lee GY, Carcaboso AM, Mumm JS, Safieh LA and Eberhart CG.
ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma
Oncogene . 38(12): 2056-2075. Nº de cites: 34
-
Winter U, Aschero R, Fuentes F, Buontempo F, Zugbi S, Sgroi M, Sampor C, Abramson DH, Carcaboso AM and Schaiquevich P.
Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 20(5): . Nº de cites: 17
-
Puerta-Roldan P, López VS, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J, Thomas C and Guillen-Quesada A.
Vanishing diffuse leptomeningeal contrast enhancement in an infant with choroid plexus papilloma.
ACTA NEUROCHIRURGICA . 161(2): 351-354. Nº de cites: 4
-
Abu Arja MH, Stanek JR, Morales-La Madrid A, Lassaletta A, Bartels U, Qaddoumi I, Finlay JL and Osorio DS.
The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource.
CHILDS NERVOUS SYSTEM . 35(2): 257-265. Nº de cites: 13